Beyond the pale., page-6

Not likely Hoy -

remember this announcing the organizational restructure:

https://www.asx.com.au/asxpdf/20180615/pdf/43vss1rx8bh4zs.pdf

"This restructure reflects the strengthening commitment and confidence of Benitec's major shareholder, Nant Capital'

A month after this statement came the Axovant deal and then the chairman's presentation in November. The narrative of the company conducting a strategic realignment of its clinical pipeline and business model is very much intact. There is a delay is the finalization of the pipeline but I would suggest it will be worth the wait.

Good luck all holders.